Clinical trial
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
NCT00424151 · Silkiss, Rona Z., M.D., FACS, Other · Completed
Key facts
| NCT number | NCT00424151 |
|---|---|
| Title | Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy |
| Official title | Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy Phase I/II |
| Lead sponsor | Silkiss, Rona Z., M.D., FACS, Other |
| Collaborators | Lauer, Simeon, M.D. Reier, Alice M.D. Coleman, Morton M.D. |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graves' Dysthyroid Ophthalmopathy, Thyroid Related Orbitopathy |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 12 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Oct 6, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: